Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program

PURPOSE: Evidence-based guidelines inform treatment decisions for patients for whom germline genetic information is available. Our real-time tumor sequencing program, which makes precision treatment decisions for patients with cancer, produces matched germline information, providing a unique opportu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JCO Precis Oncol
Auteurs principaux: Hertz, Daniel L., Glatz, Andrew, Pasternak, Amy L., Lonigro, Robert J., Vats, Pankaj, Wu, Yi-Mi, Anderson, Bailey, Rabban, Erica, Mora, Erika, Frank, Kevin, Robinson, Dan R., Mody, Rajen J., Chinnaiyan, Arul
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2018
Sujets:
Original Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7434089/
https://ncbi.nlm.nih.gov/pubmed/32832831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.18.00011
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires